Drugmaker Sun Pharmaceutical Industries has inked an agreement with Zaza Industrial Holdings KK (Japan) to sell 100 per cent shares in its step-down subsidiary Sun Pharma Japan Technical ...
Sun Pharmaceutical Industries share price gained in the early trade on January 1 after the company is going to sell its entire holding in Japanese subsidiary. At 09:26am, Sun Pharmaceutical ...
Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.28% to 1,889.80 Indian rupees Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the ...
Shares of Sun Pharmaceutical Industries Ltd. 524715 slipped 1.54% to 1,849.10 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE ...
Stocks picks for 2025: M&M, Sun Pharma, and Dalmia Bharat are the top three stock picks by Sumeet Bagadia of Choice Broking for the new year with significant potential for long-term-based returns.( ...
Thus, it is expected that the stock may see a price target of Rs. 4270 in 8 to 10 months. Sun Pharma has been maintaining its bullish momentum as prices are seen holding well above its 200-DEMA on ...
Overview: Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is a contract research company focused on drug research and development in China, with a market cap of CN¥4.37 billion. Operations ...
Vibha D Sanghvi, one of the promoters of Sun Pharma, has acquired two premium apartments in the prestigious Naman Xana on Dr. Abdul Gaffar Khan Road in Worli with the total transaction amounting ...
Overview: Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is a contract research company focused on drug research and development in China, with a market cap of CN¥4.37 billion. Operations: ...
Sun Pharmaceutical Industries: The pharma major has entered into an agreement with Zaza Industrial Holdings KK, Japan, to sell 100 per cent of its shares in Sun Pharma Japan Technical Operations ...
Sun Pharma will take up the amalgamation of five wholly-owned subsidiaries at an equity shareholder meet next month, the company said. The subsidiaries are being amalgamated as part of ongoing ...